We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
-7.51%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$159M
AUM Growth
-$12.3M
Cap. Flow
+$3.28M
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
674
New
15
Increased
177
Reduced
151
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 20.79%
2 Real Estate 15.82%
3 Healthcare 13%
4 Industrials 11.82%
5 Consumer Staples 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTS icon
526
Sensus Healthcare
SRTS
$50.4M
$3K ﹤0.01%
221
SUPN icon
527
Supernus Pharmaceuticals
SUPN
$2.8B
$3K ﹤0.01%
77
SWBI icon
528
Smith & Wesson
SWBI
$642M
$3K ﹤0.01%
310
TTC icon
529
Toro Company
TTC
$9.53B
$3K ﹤0.01%
31
VUZI icon
530
Vuzix
VUZI
$225M
$3K ﹤0.01%
600
WMB icon
531
Williams Companies
WMB
$87.8B
$3K ﹤0.01%
111
XPO icon
532
XPO
XPO
$23.6B
$3K ﹤0.01%
123
XSW icon
533
State Street SPDR S&P Software & Services ETF
XSW
$501M
$3K ﹤0.01%
29
TUP
534
DELISTED
Tupperware Brands Corporation
TUP
$3K ﹤0.01%
519
HEP
535
DELISTED
Holly Energy Partners, L.P.
HEP
$3K ﹤0.01%
175
-332
-65% -$5.75K
JPS
536
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$3K ﹤0.01%
500
ABMD
537
DELISTED
Abiomed Inc
ABMD
$3K ﹤0.01%
11
THER
538
DELISTED
THERATECHNOLOGIES INC COM
THER
$3K ﹤0.01%
1,193
ALGN icon
539
Align Technology
ALGN
$12.5B
$2K ﹤0.01%
11
ASRT
540
DELISTED
Assertio
ASRT
$2K ﹤0.01%
62
AUPH icon
541
Aurinia Pharmaceuticals
AUPH
$2.05B
$2K ﹤0.01%
200
AXGN icon
542
Axogen
AXGN
$2.59B
$2K ﹤0.01%
170
BN icon
543
Brookfield
BN
$111B
$2K ﹤0.01%
104
CC icon
544
Chemours
CC
$2.24B
$2K ﹤0.01%
100
CLDX icon
545
Celldex Therapeutics
CLDX
$3.45B
$2K ﹤0.01%
73
CRL icon
546
Charles River Laboratories
CRL
$13.3B
$2K ﹤0.01%
8
DBEF icon
547
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.42B
$2K ﹤0.01%
72
-2,130
-97% -$76K
DNOW icon
548
DNOW Inc
DNOW
$3.03B
$2K ﹤0.01%
150
DVAX
549
DELISTED
Dynavax Technologies
DVAX
$2K ﹤0.01%
220
EXEL icon
550
Exelixis
EXEL
$12.9B
$2K ﹤0.01%
117

Similar funds

Truvestments Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Truvestments Capital held 674 positions worth $159M, down 7.2% from $171M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Truvestments Capital's Q3 2022 filing shows 15 new, 177 increased, 151 reduced and 31 closed positions. Its largest new stake was Alexandria Real Estate Equities: 500 shares worth $70K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.52M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Real Estate and Healthcare.

  • Truvestments Capital's largest Q3 2022 buy was Alexandria Real Estate Equities: 500 shares worth $70K.
  • Truvestments Capital added most to AFC Gamma in Q3 2022, an estimated $241K increase.
  • Truvestments Capital's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.52M.
  • Truvestments Capital fully exited NEOPHOTONICS CORP in Q3 2022, selling an estimated $166K.
  • Truvestments Capital's ten largest holdings make up 21% of its $159M portfolio in Q3 2022.
  • Truvestments Capital opened 15 new positions and closed 31 in Q3 2022.
  • Truvestments Capital's portfolio value fell 7.2% quarter-over-quarter to $159M.

Based on Truvestments Capital's 13F filing for Q3 2022, filed 15 Nov 2022.